Moreover, in cells in the TME, the nuclear localization of FAK has been evidenced to support a cancer-progressive microenvironment, e.g., through the downmodulation of anti-tumor immunity, thereby creating an immunosuppressive TME. Here, PTK2 is linked to neoplasm.